Company / Working Capital per Share
GYRE THERAPEUTICS, INC. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.97
FY2025
5-year range
$0.49 / $1.69
FY2021-FY2025
Trend
+64.8%
vs FY2024
Sector context
#180 of 210
Health Care
What the data says
GYRE THERAPEUTICS, INC.'s working capital per share of $0.97 is lower than 86% of companies in the Health Care sector (FY2025). Working Capital per Share has increased for 3 consecutive years, from $0.49 in FY2022 to $0.97 in FY2025.
Based on SEC 10-K filings.
0.97 in FY2025 with a 5-year CAGR of -30.4%.
Improved from $0.58 to $0.97 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +25.4%
- 5-Year CAGR
- -30.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 210This company $0.97 Sector average $118.60
▼
-99.2% below sector average
Key checks
Key Insights
- GYRE THERAPEUTICS, INC.'s working capital per share has grown for 3 consecutive years.
- In FY2025, working capital per share increased 64.8% year-over-year.
- Ranks #180 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2016.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.97 | +64.8% |
| FY2024 | $0.59 | +1.1% |
| FY2023 | $0.58 | +18.3% |
| FY2022 | $0.49 | -70.7% |
| FY2021 | $1.69 | -71.7% |
| FY2020 | $5.96 | +6.0% |
| FY2019 | $5.62 | -71.3% |
| FY2018 | $19.60 | +121.0% |
| FY2017 | $8.87 | -55.6% |
| FY2016 | $19.96 | -80.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026